
How evidence landscapes contribute to the success of precision medicine
When proven effective, precision medicines are truly amazing: Patients with a specific biomarker get a precise, effective treatment, while patients without are spared unnecessary toxicity and burden. However, clinical trials for precision medicines are inherently more complicated than traditional clinical trials, and if not planned carefully, their results can be uninformative.